Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SEER
#3273
Seer, Inc. Class A Common Stock
1.7
2
-16.50%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-16.50%
Monatliche Änderung
-9.47%
6 month change
-16.50%
Jahresänderung
-20.74%
Vorheriger Schlusskurs
2.0
6
Open
1.7
2
Bid
Ask
Low
1.7
2
High
1.7
2
Volumen
15
Märkte
Aktien
Gesundheitswesen
SEER
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
54.92 M
55.74 M
54.82 M
52.29 M
51.76 M
—
Valuation ratios
Enterprise value
310.87 M
373.54 M
246.02 M
323.77 M
318.21 M
1.26 B
Price to earnings ratio
-1.53
-1.66
-1.2
-1.54
-1.6
-6
Price to sales ratio
8.55
10.16
6.8
7.91
7.81
32.69
Price to cash flow ratio
2.78
3.12
2.22
2.49
2.85
10.68
Price to book ratio
0.08
0.44
0.08
0.1
0.11
0.73
Enterprise value to EBITDA ratio
-3.85
-4.41
-3.03
-4.34
-4.56
-16.35
Profitability ratios
Return on assets %
0.06
0.06
0.06
0.06
0.06
0.24
Return on equity %
0.06
0.07
0.06
0.07
0.07
0.26
Return on invested capital %
—
76.16
75.02
81.19
75.75
308.12
Gross margin %
48.07
50.63
49.01
52.11
51.2
202.95
Operating margin %
603.3
587.2
493.01
506.79
469.45
2 056.45
EBITDA margin %
-509.62
-494.65
-390.7
-438.63
-382.09
-1 706.08
Net margin %
528.97
543.55
474.39
479.49
442.47
1 939.89
Liquidity ratios
Quick ratio
17.88
16.04
18.81
18.51
13.71
67.07
Current ratio
18.36
16.53
19.34
19.15
14.25
69.27
Inventory turnover
0.01
0.01
0
0.01
0
0.02
Asset turnover
0.01
0.01
0.01
0.01
0.01
0.05
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.23
0.18
0.19
0.25
0.13
0.76
EBIT per share
-0.4
-0.38
-0.35
-0.35
-0.33
-1.41
EBITDA per share
-0.34
-0.32
-0.28
-0.3
-0.27
-1.17
Total debt per share
—
—
—
—
—
—
Cash per share
4.05
4.8
4.8
4.48
4.34
18.42
Net current asset value per share
4.32
4.06
4.3
3.84
3.7
15.9
Tangible book value per share
5.63
5.25
5.24
4.96
4.83
20.28
Working capital per share
4.08
3.82
4.07
3.64
3.44
14.97
Book value per share
5.63
5.25
5.24
4.91
4.69
20.09
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
Nachrichten
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer 4분기 실적 부진: 설치 기반 67% 급증, 매출은 기대에 못 미쳐
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
시어 Q4 실적 예상치를 넘어, 수익 에상치보다 저조
Seer earnings beat by $0.02, revenue fell short of estimates
Seer, US HUPO 컨퍼런스에서 프로테오믹스 기술 선보일 예정
Seer to showcase proteomics technology at US HUPO conference
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
Seer, 프로테오믹스 혁신 주도: CG MedTech 포럼
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way